AngioBio
AngioBio is a privately held San Diego supplier of research antibodies for angiogenesis and lymphangiogenesis, serving academic institutions, pharmaceutical companies, and clinical research centers via direct sales, Fisher Scientific, and international distributors.
- Company typePrivate
- Founded2004
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What AngioBio does
AngioBio is a privately held, San Diego-based specialty biotechnology supplier founded in 2004 that develops and sells a focused catalog of research antibodies targeting angiogenesis and lymphangiogenesis. Its core technology is a curated portfolio of polyclonal, monoclonal, and Protein A-purified antibodies against lymphatic and blood vascular endothelial markers, principally LYVE-1, Prox1, Podoplanin, CD31, and CD34, with host species spanning rabbit, rat, mouse, and hamster. Products are validated for immunohistochemistry on frozen and paraffin sections, Western blotting, FACS sorting, and immunoprecipitation, and PE-conjugated formats extend use into direct-stain workflows.
The company operates a lean, asset-light commercial model. Antibodies are priced as one-time unit sales in the $300-$350 range, with credit on net 30 terms and FOB San Diego shipping. AngioBio serves academic research institutions, pharmaceutical and biotechnology companies, and clinical/medical research centers, and its products have been cited in publications in Nature, Science, JCI, Blood, and PNAS, with bioz.com peer ratings of 92-93/100 on flagship SKUs.
Distribution runs through direct US orders (phone, fax, email), the Fisher Scientific US catalog, and twelve regional distributors covering Austria, Benelux, Brazil, China, Finland, France, Israel and the broader Middle East, Japan, Korea, Taiwan, Italy, and Canada. Pricing has been described as 'inflation-defying,' underscoring a strategy of stable, volume-oriented sales over premiumization. The company has been operating for approximately 20 years with no disclosed funding rounds, headcount, institutional investors, or M&A activity in the available source material.
AngioBio firmographics
Firmographics- Name
- AngioBio
- Legal name
- AngioBio
- Website
- https://angiobio.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- AngioBio is a privately held San Diego supplier of research antibodies for angiogenesis and lymphangiogenesis, serving academic institutions, pharmaceutical companies, and clinical research centers via direct sales, Fisher Scientific, and international distributors.
- Ownership category
- akta.pro rank
AngioBio industry classification
Industry- Product category
- Research Antibodies
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)
Keywords
Where AngioBio is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
AngioBio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Research Antibody Sales: One-time sale of research antibodies for angiogenesis and lymphangiogenesis research. Products include various antibodies such as Anti-Mouse LYVE-1, Anti-Human LYVE-1, Anti-Prox1, and Anti-Podoplanin antibodies sold in standard sizes.
- IHC Reagent Sales: Sale of immunohistochemistry grade reagents including Anti-Human CD31 and Anti-Human CD34 monoclonal antibodies for measuring blood vessel density in tumors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Anti-Mouse LYVE-1 Antibody - 100 μg (0.1 ml) |
| Unit Pricing | Pay-as-you-go | Anti-Prox1 Antibody - 100 μg (0.1 ml) Protein A purified |
| Unit Pricing | Pay-as-you-go | IHC Grade Reagents |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
AngioBio product offering
Product offeringCore offering
AngioBio manufactures and sells a specialized catalog of research antibodies for angiogenesis and lymphangiogenesis research. The product line centers on lymphatic and blood vascular endothelial markers (LYVE-1, Prox1, Podoplanin, CD31, CD34) supplied in multiple host species and formulations for immunohistochemistry, Western blotting, FACS sorting, and immunoprecipitation. Customers include academic research institutions, pharmaceutical companies, and clinical research organizations, served directly and through Fisher Scientific in the US plus international distributors worldwide.
Product overview
AngioBio is a specialized biotechnology company offering a focused portfolio of research antibodies for angiogenesis and lymphangiogenesis studies. The product line centers on lymphatic and blood vascular endothelial markers including LYVE-1, Prox1, Podoplanin, CD31, and CD34 antibodies, available in multiple host species formats (rabbit, rat, mouse, hamster) and formulations (unconjugated, PE-conjugated). Products are designed for immunohistochemistry (frozen and paraffin sections), Western blotting, FACS sorting, and immunoprecipitation applications. The company sells directly and through Fisher Scientific (USA) and international distributors across Austria, Benelux, Brazil, China, Finland, France, Israel, Japan, Korea, Taiwan, Italy, and Canada.
Differentiator
Problem solved
Functional benefit
Products and services
- Anti-Mouse LYVE-1 Antibody Rabbit polyclonal antibody (catalog 11-034, 100 μg at $300) raised against the extracellular domain of mouse LYVE-1; works for both frozen and paraffin sections in immunohistochemistry and detects a 70 kD LYVE-1 band in Western blotting.
- Anti-Human LYVE-1 Antibody Rabbit IgG antibody (catalog 11-032) that detects human LYVE-1 on lymphatic endothelial cell surfaces by immunohistochemistry and a 70 kD band in Western blotting.
- Anti-Prox1 Antibody Rabbit polyclonal antibody (catalog 11-002) against Prox1, the master switch for lymphatic endothelial phenotype; works for immunohistochemistry with formalin-fixed paraffin embedded sections and Western blotting.
- Anti-Prox1 Antibody (Protein A Purified) Protein A purified rabbit IgG version of anti-Prox1 antibody (catalog 11-002P, 100 μg at $350); cross-reacts with human, mouse, and rat Prox1; suitable for immunohistochemistry and Western blotting.
- Anti-Mouse Podoplanin Monoclonal Antibody Hamster monoclonal antibody recognizing mouse podoplanin on cell surfaces; lymphatic endothelium marker that distinguishes lymphatic from blood vessels; works with paraffin sections and detects a 36-40 kDa band in Western blotting.
- Anti-Human Podoplanin Monoclonal Antibody Mouse monoclonal antibody (IgG) against human podoplanin; works for immunohistochemistry with formalin-fixed paraffin embedded sections and FACS sorting.
- Anti-Human Podoplanin Monoclonal Antibody NZ-1 Rat monoclonal antibody (IgG2a, catalog 11-009) against human podoplanin; works for immunohistochemistry with formalin-fixed paraffin embedded sections, Western blotting, immunoprecipitation, and FACS sorting.
- Anti-Rat Podoplanin Monoclonal Antibody Mouse monoclonal antibody (IgG) against rat podoplanin (catalog 11-035, 0.2 ml); works for immunohistochemistry with formalin-fixed paraffin embedded sections, Western blotting, and FACS sorting.
- Anti-Human CD31 Monoclonal Antibody (JC/70A) Mouse monoclonal antibody against CD31 (PECAM-1), a glycoprotein on endothelial cells and platelets; used to detect endothelial cells in tissue sections for measuring blood vessel density in tumors; works with paraffin sections and FACS sorting.
- Anti-Human CD34 Monoclonal Antibody (QBEnd/10) Mouse monoclonal antibody (IgG1) against human CD34, a sialomucin-like adhesion molecule on hematopoietic stem cells and vascular endothelial cells; used to detect endothelial cells and isolate CD34+ progenitor cells; works with paraffin sections and FACS sorting.
- Anti-Human Podoplanin Monoclonal Antibody-PE PE (Phycoerythrin)-conjugated rat monoclonal antibody (IgG2a) against human podoplanin; directly usable in FACS sorting and immunostaining without secondary antibody.
- Anti-Mouse Podoplanin Monoclonal Antibody-PE PE (Phycoerythrin)-conjugated hamster monoclonal antibody recognizing mouse podoplanin; directly usable in FACS sorting and immunostaining; detects a 36-40 kDa band in Western blotting.
Quantifiable outcome
- Products cited in publications in Nature (multiple papers), Science, JCI, Blood, PNAS, and other high-impact journals
- +3 more outcomes
Companies that use AngioBio
Customer profileNamed customers17 records
Segments3 records
Ideal customer profiles3 records
AngioBio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
AngioBio partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered primary and regional.
- Fisher ScientificprimaryUS distributor for AngioBio products. Products can be found on Fisher Scientific's catalog by searching 'angiobio'. Tel: +1-800-766-7000, Fax: +1-800-926-1166.
- EubioregionalAustrian distributor located at Schwendergrasse 17, 1150 Vienna, Austria. Tel: +43-1-8950145, Fax: +43-1-8950145-14, Website: www.eubio.at
- Bio-Connect Service BVregionalBenelux distributor located at Begonialaan 3A, 6851 TE Huissen, The Netherlands. Tel: +31-(0)26 326 4450, Website: www.bio-connect.nl
- Life-SciencesregionalBrazilian distributor located at Rua Fabia-1080, 05051-30 São Paulo, Brazil. Tel: 55-11-3675-7561, Email: [email protected]
- Beijing Protein InnovationregionalChinese distributor at Beijing Airport Industrial Zone B-8, Beijing, P.R. China 101318. Tel: 800-810-0873, 86-10-80493132, Email: [email protected]
- Nuppulinnan laboratoriopalvelu OyregionalFinnish distributor at Jokelantie 346, Halli D, 05430 Nuppulinna, Finland. Tel: 020 792 0350, Email: [email protected]
- EuromedexregionalFrench distributor at 24 Rue Des Tuileries, 67460 Souffelweyersheim, France. Tel: +33-3-881807-27, Website: www.euromedex.com
- BioTAG LtdregionalDistributor for Israel, Egypt, Greece, Turkey and most of Middle East. PO Box 4067, Kafar Yona Zip Code:4031016, Israel. Tel: 972-52-5522748
- Cosmo Bio Co., LtdregionalJapanese distributor at 2-2-20 Toyo, Koto-ku, Tokyo 135-0016, Japan. Tel: 03-5632-9616, Fax: 03-5632-9614, Website: www.cosmobio.co.jp
- Lim & BiosystemsregionalKorean distributor at Giheung ICT-Vally SKV1, B-1208, 58 Giheung-ro, Giheung-gu, Yongin-si, Gyeonggi-do, 16976 Korea. Tel: 82-31-630-3790, Email: [email protected]
- Biochiefdom International Co., LtdregionalTaiwanese distributor at 12F-1, No.89, Sec.1, Beixin Rd, Xindian District, New Taipei City 23147, Taiwan. Tel: 886-2-2916-1188, Website: www.bio-chief.com.tw
- Società Italiana Chimici SrlregionalItalian distributor at Via Rio nell' Elba, 140, 00138 ROMA, Italy. Tel: +39-06-8818936/8800211, Email: [email protected]
- CedarlaneregionalCanadian distributor at 4410 Paletta Court, Burlington, Ontario, L7L 5R2. Website: www.cedarlanelabs.com
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
AngioBio competitors and assessment
Company assessmentDirect peers
- R&D Systems (Bio-Techne): R&D Systems, part of Bio-Techne, supplies high-quality antibodies and reagents for cancer, immunology, and stem cell research, with overlapping target areas to AngioBio including endothelial and lymphatic markers. Comparable business model of catalog antibody sales to research customers.
- Abcam: Abcam is a leading global supplier of research-grade antibodies including lymphatic, vascular, and CD31/CD34 markers, with overlapping product categories serving the same academic and pharma research customers as AngioBio. Now part of Danaher, it offers far greater catalog breadth and scale.
- Miltenyi Biotec: Miltenyi Biotec manufactures antibodies and reagents for cell biology, immunology, and flow cytometry applications, with overlap to AngioBio in vascular and lymphatic marker antibodies and shared customer segments in academic and translational research.
- OriGene Technologies: OriGene Technologies is a specialty antibody and reagent supplier offering monoclonal and polyclonal antibodies for cancer, immunology, and vascular research, with overlapping product categories and customer segments to AngioBio.
- Santa Cruz Biotechnology: Santa Cruz Biotechnology supplies a broad catalog of monoclonal and polyclonal research antibodies covering lymphatic, endothelial, and cancer markers, overlapping directly with AngioBio's core offerings to academic and pharma researchers.
- Proteintech: Proteintech is a rapidly growing specialty antibody manufacturer known for high-quality antibodies cited in publications, including markers relevant to angiogenesis and vascular biology, directly comparable to AngioBio's catalog antibody business model.
- Novus Biologicals (Bio-Techne): Novus Biologicals, part of Bio-Techne, is a research antibody and reagent supplier with extensive coverage of vascular biology and lymphatic markers, serving the same academic and pharma research customer base as AngioBio.
- Cell Signaling Technology: Cell Signaling Technology (CST) is a major research antibody supplier known for highly validated antibodies used in cancer and vascular biology, including podoplanin and CD31 clones. Directly comparable to AngioBio in serving IHC, Western blot, and flow cytometry applications at research institutions.
Broad incumbents
- Thermo Fisher Scientific: Thermo Fisher Scientific is a global life sciences incumbent offering research antibodies through multiple brands (Invitrogen, eBioscience, Pierce) covering lymphatic and vascular markers, competing broadly with AngioBio but as part of a much larger portfolio including instruments, reagents, and services.
- MilliporeSigma: MilliporeSigma (the life science business of Merck KGaA) supplies an extensive catalog of research antibodies and reagents, including many lymphatic and vascular markers, competing with AngioBio across the same research customer base but at much greater scale and breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
AngioBio social profiles
Digital presenceAngioBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
AngioBio leadership team
Management profileNumber of profiles
AngioBio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AngioBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AngioBio
What does AngioBio do?
AngioBio manufactures and sells a specialized catalog of research antibodies for angiogenesis and lymphangiogenesis research. The product line centers on lymphatic and blood vascular endothelial markers (LYVE-1, Prox1, Podoplanin, CD31, CD34) supplied in multiple host species and formulations for immunohistochemistry, Western blotting, FACS sorting, and immunoprecipitation. Customers include academic research institutions, pharmaceutical companies, and clinical research organizations, served directly and through Fisher Scientific in the US plus international distributors worldwide.
Is AngioBio a public or private company?
AngioBio is a private company. It is classified as unknown and is currently operating.
When was AngioBio founded?
AngioBio was founded in 2004. It employs 1 to 10 people.
Where is AngioBio based?
AngioBio is headquartered in San Diego, United States, in the North America region.
How does AngioBio make money?
Two revenue lines are on record. Research Antibody Sales are the primary driver. The others are IHC Reagent Sales.
Who are AngioBio's main competitors?
Direct peers on record are R&D Systems (Bio-Techne), Abcam, Miltenyi Biotec, OriGene Technologies, Santa Cruz Biotechnology, Proteintech, Novus Biologicals (Bio-Techne) and Cell Signaling Technology. Broad incumbents are Thermo Fisher Scientific and MilliporeSigma.
Does AngioBio have an API?
No public API is recorded for AngioBio.
What industry is AngioBio in?
AngioBio's product category is Research Antibodies. Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering). Its NAICS code is 325413 and its SIC code is 2835.